Cargando…

Peptide Receptor Radionuclide Therapy and Primary Brain Tumors: An Overview

Primary brain tumors (PBTs) are some of the most difficult types of cancer to treat, and despite advancements in surgery, chemotherapy and radiotherapy, new strategies for the treatment of PBTs are needed, especially for those with poor prognosis such as inoperable/difficult-to-reach lesions or rela...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cimini, Andrea, Ricci, Maria, Russo, Francesca, Egidi, Martina, Calabria, Ferdinando, Bagnato, Antonio, Schillaci, Orazio, Chiaravalloti, Agostino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470698/ https://www.ncbi.nlm.nih.gov/pubmed/34577572 http://dx.doi.org/10.3390/ph14090872

Ejemplares similares

18F-FDOPA PET/CT SUV-Derived Indices and Volumetric Parameters Correlation in Patients with Primary Brain Tumors
por: Chiaravalloti, Agostino, et al.
Publicado: (2021)

Molecular Imaging in Pediatric Brain Tumors
por: Chiaravalloti, Agostino, et al.
Publicado: (2019)

MGMT Promoter Methylation and IDH1 Mutations Do Not Affect [(18)F]FDOPA Uptake in Primary Brain Tumors
por: Cimini, Andrea, et al.
Publicado: (2020)

A Rare Case of Pulmonary Schistosomiasis: (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Findings
por: Cimini, Andrea, et al.
Publicado: (2020)

A Patient with a Benign and a Malignant Primary Pulmonary Meningioma: An Evaluation with 18F Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Computed Tomography with Iodinated Contrast
por: Cimini, Andrea, et al.
Publicado: (2019)

Theragnostic Aspects and Radioimmunotherapy in Pediatric Tumors
por: Cimini, Andrea, et al.
Publicado: (2020)

Positron Emission Tomography (PET) and Neuroimaging in the Personalized Approach to Neurodegenerative Causes of Dementia
por: Ricci, Maria, et al.
Publicado: (2020)

Tau Biomarkers in Dementia: Positron Emission Tomography Radiopharmaceuticals in Tauopathy Assessment and Future Perspective
por: Ricci, Maria, et al.
Publicado: (2021)

A Rare Case of Primary Uterine Non-Hodgkins's Lymphoma with Involvement of Right Ovary: Staging with 18F FDG PET/CT and Iodinated Contrast CT
por: Lamacchia, Feliciana, et al.
Publicado: (2019)

Complementary Role of Combined Indirect and Direct Cardiac Sympathetic (Hyper)Activity Assessment in Patients with Heart Failure by Spectral Analysis of Heart Rate Variability and Nuclear Imaging: Possible Application in the Evaluation of Exercise Training Effects
por: Iellamo, Ferdinando, et al.
Publicado: (2022)

Medical Imaging in the Diagnosis of Schistosomiasis: A Review
por: Cimini, Andrea, et al.
Publicado: (2021)

The Brain Metabolic Correlates of the Main Indices of Neuropsychological Assessment in Alzheimer’s Disease †
por: Chiaravalloti, Agostino, et al.
Publicado: (2020)

(131)I Uptake in Bronchiectasis Detected by Single Photon Emission Computed Tomography/Computed Tomography during Follow-up of Thyroid Cancer
por: Calabria, Ferdinando, et al.
Publicado: (2019)

Subependymal Spread of Glioblastoma Multiforme in Positron Emission Tomography/Computed Tomography
por: Chiaravalloti, Agostino, et al.
Publicado: (2017)

Evaluation of Task-Related Brain Activity: Is There a Role for (18)F FDG-PET Imaging?
por: Chiaravalloti, Agostino, et al.
Publicado: (2019)

Peptide Receptor Radionuclide Therapy
por: Hofland, Johannes, et al.
Publicado: (2022)

Multimodality radionuclide imaging in fever of unknown origin presenting with a solitary spleen lesion
por: Filippi, Luca, et al.
Publicado: (2022)

Radiolabeled Dendrimer Coated Nanoparticles for Radionuclide Imaging and Therapy: A Systematic Review
por: Conte, Miriam, et al.
Publicado: (2023)

Peptide Receptor Radionuclide Therapy in Thyroid Cancer
por: Gubbi, Sriram, et al.
Publicado: (2022)

The Current Role of Peptide Receptor Radionuclide Therapy in Meningiomas
por: Fodi, Christina-Katharina, et al.
Publicado: (2022)

Peptide Receptor Radionuclide Therapy (PRRT): Innovations and Improvements
por: Merola, Elettra, et al.
Publicado: (2023)

Prognostic Value of (18)F-Choline PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Radium-223
por: Filippi, Luca, et al.
Publicado: (2020)

Functional Correlates of Microglial and Astrocytic Activity in Symptomatic Sporadic Alzheimer’s Disease: A CSF/(18)F-FDG-PET Study
por: Bonomi, Chiara Giuseppina, et al.
Publicado: (2023)

Value of Peptide Receptor Radionuclide Therapy as Neoadjuvant Treatment in the Management of Primary Inoperable Neuroendocrine Tumors
por: Opalińska, Marta, et al.
Publicado: (2021)

Potentiation of Peptide Receptor Radionuclide Therapy by the PARP Inhibitor Olaparib
por: Nonnekens, Julie, et al.
Publicado: (2016)

Peptide Receptor Radionuclide Therapy for a Phosphaturic Mesenchymal Tumor
por: Häfliger, Simon, et al.
Publicado: (2020)

Peptide Receptor Radionuclide Therapy: Looking Back, Looking Forward
por: Feijtel, Danny, et al.
Publicado: (2020)

The Effects of Peptide Receptor Radionuclide Therapy on the Neoplastic and Normal Pituitary
por: Marques, Pedro
Publicado: (2023)

Brain metabolic changes in Hodgkin disease patients following diagnosis and during the disease course: An (18)F-FDG PET/CT study
por: CHIARAVALLOTI, AGOSTINO, et al.
Publicado: (2015)

Prognostic and Theranostic Applications of Positron Emission Tomography for a Personalized Approach to Metastatic Castration-Resistant Prostate Cancer
por: Filippi, Luca, et al.
Publicado: (2021)

Neuroendocrine metastasis to the thyroid from unknown primary and extrathyroidal disease response to peptide receptor radionuclide therapy
por: Khessib, Tasnim, et al.
Publicado: (2023)

Is cerebral glucose metabolism related to blood–brain barrier dysfunction and intrathecal IgG synthesis in Alzheimer disease?: A (18)F-FDG PET/CT study
por: Chiaravalloti, Agostino, et al.
Publicado: (2016)

Peptide Receptor Radionuclide Therapy of Differentiated Thyroid Cancer: Efficacy and Toxicity
por: Czepczyński, Rafał, et al.
Publicado: (2014)

Australian experience of peptide receptor radionuclide therapy in lung neuroendocrine tumours
por: Lim, Lisi Elizabeth, et al.
Publicado: (2020)

Strategies Towards Improving Clinical Outcomes of Peptide Receptor Radionuclide Therapy
por: Minczeles, N.S., et al.
Publicado: (2021)

Pituitary function following peptide receptor radionuclide therapy for neuroendocrine tumours
por: Elston, Marianne S., et al.
Publicado: (2021)

Functional correlates of TSH, fT3 and fT4 in Alzheimer disease: a F-18 FDG PET/CT study
por: Chiaravalloti, Agostino, et al.
Publicado: (2017)

Detection Rate and Clinical Impact of PET/CT with (18)F-FACBC in Patients with Biochemical Recurrence of Prostate Cancer: A Retrospective Bicentric Study
por: Filippi, Luca, et al.
Publicado: (2022)

DNA Damage Repair Defects and Targeted Radionuclide Therapies for Prostate Cancer: Does Mutation Really Matter? A Systematic Review
por: Filippi, Luca, et al.
Publicado: (2022)

Cortico-subcortical metabolic correlates of olfactory processing in healthy resting subjects
por: Alessandrini, Marco, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8scfiasbbhl5mf1o8lq1b6ts4h